2023年生命科学热点回眸
Research highlights of bioscience in 2023
张文阳 1杨昱鸽 1朱恒乐 1朱芳 2王呈呈 2胡荣贵3
作者信息
- 1. 中国科学院大学分子细胞科学卓越创新研究中心,上海 200032
- 2. 贵州大学医学院,贵阳 550025
- 3. 中国科学院大学分子细胞科学卓越创新研究中心,上海 200032;贵州大学医学院,贵阳 550025
- 折叠
摘要
2023年,生命科学多个领域的研究取得突破性进展.重点回顾其中一部分已经、正在和未来非常可能改变人类对生命科学研究的前沿热点:人工智能正越来越成为生命科学和医学应用的有力且重要工具;基于GLP-1激动剂的出现和空前的广泛应用;相分离、体外胚胎模型、神经科学、发育生物学等领域新的技术的进一步优化和应用;针对β-淀粉样蛋白的抗体疗法、干细胞及免疫疗法、mRNA疫苗、CRISPR基因编辑疗法等新的临床治疗手段的出现和初步临床应用.这些研究进展不但进一步拓展人类对生命本质奥秘的理解,也正在为阿尔兹海默症、肿瘤、病毒感染等一系列重大人类疾病的患者带来福音.
Abstract
In 2023,breakthrough advancements were made in various fields of life sciences.This article mainly reviews some of those developments that have changed and will likely continue to change our technological,perspective,and investigative approaches to life sciences:The artificial intelligence as an increasingly powerful and important tool for applications in life sciences and medicine;The emergence and unprecedentedly widespread use of GLP-1 agonists;the further optimization and application of new technologies in areas such as phase separation,in vitro embryo models,neuroscience,and developmental biology;and the advent and initial clinical application of new clinical treatments like antibody therapy against beta-amyloid,stem cell and immunotherapy,mRNA vaccines,and CRISPR gene-editing therapies.These research advancements are not only further expanding our understanding of the mysteries of life itself but also bringing hope to patients suffering from a series of significant human diseases such as Alzheimer's,cancer,viral infections,and more.
关键词
人工智能/GLP-1/神经科学/疫苗研发/胚胎发育/CRISPR基因编辑/相分离Key words
artificial intelligence/GLP-1/neuroscience/vaccine research/embryonic development/CRISPR gene editing/phase separation引用本文复制引用
基金项目
科学技术部脑科学重大项目科技创新2030(2021ZD0203900)
贵州省科技计划项目(黔科合基础项目[2020]1Y086)
贵州省卫健委科学技术基金项目(gzwkj2022-219)
国家自然科学基金项目(92253302)
出版年
2024
NETL
NSTL
万方数据